StockNews.com Begins Coverage on Streamline Health Solutions (NASDAQ:STRM)

Stock analysts at StockNews.com initiated coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research report issued to clients and investors on Thursday. The brokerage set a “sell” rating on the stock.

Separately, Craig Hallum raised shares of Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September 5th.

Streamline Health Solutions Price Performance

Shares of NASDAQ:STRM opened at $2.43 on Thursday. The company has a quick ratio of 0.61, a current ratio of 0.61 and a debt-to-equity ratio of 0.66. Streamline Health Solutions has a fifty-two week low of $2.03 and a fifty-two week high of $9.75. The firm has a 50-day simple moving average of $0.75 and a 200 day simple moving average of $0.54. The company has a market cap of $150.73 million, a PE ratio of -7.59 and a beta of 1.60.

Streamline Health Solutions (NASDAQ:STRM) last announced its quarterly earnings data on Wednesday, September 11th. The company reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.01). Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%. The business had revenue of $4.48 million for the quarter.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.